SEC Form 4 · accession 0001140361-16-055011
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne Reiser
Officer — President - ResMed Europe
Period of report
Feb 23, 2016
Accepted (ET)
Feb 26, 2016 · 9:34 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | Feb 23, 2016 | M | 3,000 | $20.355 | A | 79,300 | D | |
| ResMed Common StockF2 | Feb 23, 2016 | F | 1,054 | $57.94 | D | 78,246 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF1 | $20.355 | Feb 23, 2016 | M | 3,000 | D | Feb 23, 2009 | Feb 23, 2016 | ResMed Commmon Stock | 3,000 | 0 | D |
Explanation of responses
- F1Represents date options first became exercisable. Options vest 1/4 each year on the anniversary of the grant.
- F2Disposition to issuer for payment of cost of equity security by netting of shares from expiring stock options granted on 2/23/2016.